List of Contents

Healthcare Laboratory Informatics Market Size, Share, and Trends 2024 to 2033

Healthcare Laboratory Informatics Market (By Product: Laboratory Information Management System (LIMS), Electronic Lab Notebook (ELN), Scientific Data Management System (SDMS), Chromatography Data System (CDS), Laboratory Executive System (LES); By Deployment: On-premise, Cloud-based; By Component: Service, Software; By End-use: Biotech Companies, Pharmaceuticals, Clinical, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : June 2024
  • Report Code : 4494
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare Laboratory Informatics Market 

5.1. COVID-19 Landscape: Healthcare Laboratory Informatics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare Laboratory Informatics Market, By Product

8.1. Healthcare Laboratory Informatics Market, by Product, 2024-2033

8.1.1. Laboratory Information Management System (LIMS)

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Electronic Lab Notebook (ELN)

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Scientific Data Management System (SDMS)

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Chromatography Data System (CDS)

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Laboratory Executive System (LES)

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Healthcare Laboratory Informatics Market, By Deployment

9.1. Healthcare Laboratory Informatics Market, by Deployment, 2024-2033

9.1.1. On-premise

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Cloud-based

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Healthcare Laboratory Informatics Market, By Component 

10.1. Healthcare Laboratory Informatics Market, by Component, 2024-2033

10.1.1. Service

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Software

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Healthcare Laboratory Informatics Market, By End-use 

11.1. Healthcare Laboratory Informatics Market, by End-use, 2024-2033

11.1.1. Biotech Companies

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Pharmaceuticals

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Clinical

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Healthcare Laboratory Informatics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.1.3. Market Revenue and Forecast, by Component (2021-2033)

12.1.4. Market Revenue and Forecast, by End-use (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Component (2021-2033)

12.1.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Component (2021-2033)

12.1.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.2.3. Market Revenue and Forecast, by Component (2021-2033)

12.2.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Component (2021-2033)

12.2.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Component (2021-2033)

12.2.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Component (2021-2033)

12.2.7.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Component (2021-2033)

12.2.8.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.3.3. Market Revenue and Forecast, by Component (2021-2033)

12.3.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Component (2021-2033)

12.3.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Component (2021-2033)

12.3.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Component (2021-2033)

12.3.7.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Component (2021-2033)

12.3.8.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.4.3. Market Revenue and Forecast, by Component (2021-2033)

12.4.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Component (2021-2033)

12.4.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Component (2021-2033)

12.4.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Component (2021-2033)

12.4.7.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Component (2021-2033)

12.4.8.4. Market Revenue and Forecast, by End-use (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.5.3. Market Revenue and Forecast, by Component (2021-2033)

12.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Component (2021-2033)

12.5.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Deployment (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Component (2021-2033)

12.5.6.4. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 13. Company Profiles

13.1. Competitive dashboard

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Starlims

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Agilent Technologies

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Benchling, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. LabVantage Solutions, Inc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. LabWare

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. LABLynx, Inc

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. PerkinElmer, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Tech Mahindra

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Thermo Fisher Scientific

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client